Page last updated: 2024-10-23

atenolol and Acute Generalised Exanthematous Pustulosis

atenolol has been researched along with Acute Generalised Exanthematous Pustulosis in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Owczarczyk-Saczonek, A1
Znajewska-Pander, A1
Owczarek, W1
Maciejewska-Radomska, A1
Placek, W1
Gómez Torrijos, E1
García Rodríguez, C1
Sánchez Caminero, MP1
Castro Jiménez, A1
García Rodríguez, R1
Feo-Brito, F1

Other Studies

2 other studies available for atenolol and Acute Generalised Exanthematous Pustulosis

ArticleYear
Clinicopathologic retrospective analysis of annular pustular psoriasis.
    Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2018, Volume: 27, Issue:4

    Topics: Acute Generalized Exanthematous Pustulosis; Aged; Aged, 80 and over; Antihypertensive Agents; Atenol

2018
First case report of acute generalized exanthematous pustulosis due to labetalol.
    Journal of investigational allergology & clinical immunology, 2015, Volume: 25, Issue:2

    Topics: Acute Generalized Exanthematous Pustulosis; Adrenergic Antagonists; Adult; Antihypertensive Agents;

2015